FLT vs LAB
FLT (FLT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
FLT (FLT) common stock.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
FLT does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
LAB currently screens at market cap $317.1M.
Not investment advice. Open the FLT and LAB stock pages for the full models.
Not investment advice.